Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech leadership pharma Research & Development research-development

	Profile	Recent Articles on Subject
1	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 6 days ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - 16 days ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 2 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 7 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 8 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - 9 months ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - 11 months ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - 11 months ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - 11 months ago STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast - 12 months ago STAT+: Pharmalittle: Pfizer is leaving the BIO trade group; CVS drug-pricing plan may not lower costs for consumers - 12 months ago STAT+: Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market - 12 months ago STAT+: Pharmalittle: Novo Nordisk to spend $6 billion to boost production; FDA okays world’s first vaccine for chikungunya - about 1 year ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - about 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - about 1 year ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - about 1 year ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Pharma takes aim at a wily foe — the Epstein-Barr virus - 13 days ago 2024 PharmaVoice 100s: Rare Disease Warriors - 19 days ago 2024 PharmaVoice 100s: Trailblazers - about 1 month ago 2024 PharmaVoice 100s: Standout Leaders - about 1 month ago Why pharma should redefine ‘women’s health’ - 2 months ago What 3 layoff stories reveal about pharma’s troubles - 2 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 2 months ago Is anyone taking the world’s priciest drugs? - 3 months ago What pharma has learned from AI - 4 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 5 months ago Where competition is heating up in pharma - 6 months ago The biggest questions hanging over pharma in 2024 - 10 months ago Pharma execs sound off on trends and policies they’re tracking in 2024 - 10 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - 10 months ago 3 standout digital innovations in pharma this year - 12 months ago PharmaVoice 100s: Entrepreneurs - about 1 year ago PharmaVoice 100s: Clinical trial gurus - about 1 year ago 5 minutes with — IDEA Pharma’s Mike Rea - about 1 year ago
3	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	2024 PharmaVoice 100s: Tech and AI Wizards - 20 days ago As election day nears, Trump and Harris veer in different directions on pharma - about 1 month ago 3 FDA approval dates to watch in the year’s final push - 2 months ago M&A is ready to explode, and that’s good news for pharma layoffs - 3 months ago Read to lead: 6 books pharma execs swear by - 4 months ago Pharma CFOs need R&D vigilance in tough economic times - 9 months ago
4	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 2 months ago
5	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Is pharma still fearful of the Inflation Reduction Act? - 3 months ago
6	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	June 2024 Products Column - 5 months ago Pharmacist Spotlight: Jake Galdo, PharmD, MBA - 11 months ago
7	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	April 2024 - 8 months ago 2024 - 10 months ago
8	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline - 8 months ago
9	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Pharmacists Are Vital to Heart Health - 9 months ago
10	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	Pharma has a misinformation problem — and execs could be on the hook - 9 months ago Vaxxinity is brewing up meds for a spacefaring future - 10 months ago Pharma takes a gut check of microbiome drugs - 10 months ago What are pharma’s next blockbusters? - 11 months ago Oncology drugmakers seek the sweet spot between efficacy and tolerability - 11 months ago Humans can’t shake the mosquito threat. Here’s what pharma has in the pipeline. - about 1 year ago From the rainforest to Wall Street — Jaguar Health’s big play for revitalization - about 1 year ago Has the science of anti-aging caught up with the dream of a longer life? - about 1 year ago

Journalists covering pharma